Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Uterine Corpus Cancer”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT01642082
What this trial is testing

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more
Gynecologic Oncology Group 28
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableStudy completedNCT01198171
What this trial is testing

Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer

Who this might be right for
Stage I Uterine Corpus CancerStage II Uterine Corpus CancerStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 243
Testing effectiveness (Phase 2)Study completedNCT01225887
What this trial is testing

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+6 more
Gynecologic Oncology Group 37
Not applicableStudy completedNCT03198286
What this trial is testing

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

Who this might be right for
Stage I Breast CancerStage I Cervical CancerStage I Ovarian Cancer+36 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 40
Not applicableWithdrawnNCT03902379
What this trial is testing

Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer

Who this might be right for
Endometrial CarcinomaStage 0 Fallopian Tube Cancer AJCC v7Stage I Fallopian Tube Cancer AJCC v6 and v7+53 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Study completedNCT03367923
What this trial is testing

Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors

Who this might be right for
Cancer SurvivorEndometrial CarcinomaStage I Uterine Corpus Cancer AJCC v7+4 more
Stanford University 47
Testing effectiveness (Phase 2)Ended earlyNCT02112552
What this trial is testing

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Who this might be right for
Endometrial Serous AdenocarcinomaStage IIIA Uterine Corpus CancerStage IIIB Uterine Corpus Cancer+4 more
Albert Einstein College of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT02601209
What this trial is testing

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more
National Cancer Institute (NCI) 151
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826
What this trial is testing

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Who this might be right for
Endometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01098630
What this trial is testing

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more
Gynecologic Oncology Group 778
Not applicableStudy completedNCT04269837
What this trial is testing

Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer

Who this might be right for
Malignant Female Reproductive System NeoplasmStage I Cervical Cancer AJCC v8Stage I Uterine Corpus Cancer AJCC v8+42 more
Ohio State University Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00114218
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Carcinosarcoma
Gynecologic Oncology Group 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT00977574
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 349
Not applicableActive Not RecruitingNCT04678414
What this trial is testing

Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+27 more
M.D. Anderson Cancer Center 1,410
Testing effectiveness (Phase 2)Study completedNCT00006089
What this trial is testing

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaERBB2 Gene AmplificationRecurrent Uterine Corpus Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT01307631
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00888173
What this trial is testing

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more
Gynecologic Oncology Group 45
Early research (Phase 1)Ended earlyNCT03345784
What this trial is testing

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

Who this might be right for
Cervical CarcinomaEndometrioid AdenocarcinomaMalignant Female Reproductive System Neoplasm+21 more
National Cancer Institute (NCI) 10
Load More Results
288